Gene Page: LAP3
Summary ?
GeneID | 51056 |
Symbol | LAP3 |
Synonyms | HEL-S-106|LAP|LAPEP|PEPS |
Description | leucine aminopeptidase 3 |
Reference | MIM:170250|HGNC:HGNC:18449|Ensembl:ENSG00000002549|HPRD:07516|Vega:OTTHUMG00000048214 |
Gene type | protein-coding |
Map location | 4p15.32 |
Pascal p-value | 0.007 |
Sherlock p-value | 0.761 |
eGene | Cerebellum Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs10494571 | chr1 | 183930700 | LAP3 | 51056 | 0.16 | trans | ||
rs17033273 | chr3 | 10676696 | LAP3 | 51056 | 0.15 | trans | ||
rs10515260 | chr5 | 97076547 | LAP3 | 51056 | 1.65E-5 | trans | ||
rs10515267 | chr5 | 100128201 | LAP3 | 51056 | 0.16 | trans | ||
rs9697131 | chr9 | 23695276 | LAP3 | 51056 | 0.01 | trans | ||
rs3802522 | chr10 | 28341865 | LAP3 | 51056 | 0.14 | trans | ||
rs10508730 | chr10 | 28403391 | LAP3 | 51056 | 0.14 | trans | ||
rs2508654 | chr11 | 120405519 | LAP3 | 51056 | 0.09 | trans | ||
rs11219646 | chr11 | 124279239 | LAP3 | 51056 | 0.08 | trans | ||
rs9645995 | chr13 | 47246048 | LAP3 | 51056 | 0.06 | trans | ||
rs6598553 | chr15 | 99339208 | LAP3 | 51056 | 0.11 | trans | ||
rs17342476 | chrX | 102243644 | LAP3 | 51056 | 1.388E-4 | trans | ||
rs17342483 | chrX | 102250155 | LAP3 | 51056 | 5.827E-4 | trans | ||
rs17342504 | chrX | 102272107 | LAP3 | 51056 | 1.388E-4 | trans | ||
snp_a-2138851 | 0 | LAP3 | 51056 | 1.388E-4 | trans | |||
snp_a-2059928 | 0 | LAP3 | 51056 | 1.388E-4 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG ARGININE AND PROLINE METABOLISM | 54 | 39 | All SZGR 2.0 genes in this pathway |
KEGG GLUTATHIONE METABOLISM | 50 | 34 | All SZGR 2.0 genes in this pathway |
HOLLMANN APOPTOSIS VIA CD40 UP | 201 | 125 | All SZGR 2.0 genes in this pathway |
ONKEN UVEAL MELANOMA UP | 783 | 507 | All SZGR 2.0 genes in this pathway |
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP | 206 | 111 | All SZGR 2.0 genes in this pathway |
THUM SYSTOLIC HEART FAILURE UP | 423 | 283 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA DN | 1375 | 806 | All SZGR 2.0 genes in this pathway |
CHEBOTAEV GR TARGETS UP | 77 | 62 | All SZGR 2.0 genes in this pathway |
KOINUMA COLON CANCER MSI UP | 16 | 11 | All SZGR 2.0 genes in this pathway |
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | 800 | 473 | All SZGR 2.0 genes in this pathway |
DAUER STAT3 TARGETS DN | 50 | 34 | All SZGR 2.0 genes in this pathway |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | 584 | 395 | All SZGR 2.0 genes in this pathway |
NUYTTEN EZH2 TARGETS UP | 1037 | 673 | All SZGR 2.0 genes in this pathway |
LEE TARGETS OF PTCH1 AND SUFU UP | 53 | 37 | All SZGR 2.0 genes in this pathway |
WIELAND UP BY HBV INFECTION | 101 | 66 | All SZGR 2.0 genes in this pathway |
SANA RESPONSE TO IFNG UP | 78 | 50 | All SZGR 2.0 genes in this pathway |
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN | 73 | 45 | All SZGR 2.0 genes in this pathway |
MOREAUX MULTIPLE MYELOMA BY TACI DN | 172 | 107 | All SZGR 2.0 genes in this pathway |
WANG SMARCE1 TARGETS DN | 371 | 218 | All SZGR 2.0 genes in this pathway |
ZHONG SECRETOME OF LUNG CANCER AND FIBROBLAST | 132 | 93 | All SZGR 2.0 genes in this pathway |
RIGGINS TAMOXIFEN RESISTANCE DN | 220 | 147 | All SZGR 2.0 genes in this pathway |
ACEVEDO NORMAL TISSUE ADJACENT TO LIVER TUMOR UP | 174 | 96 | All SZGR 2.0 genes in this pathway |
ACEVEDO LIVER CANCER UP | 973 | 570 | All SZGR 2.0 genes in this pathway |
IZADPANAH STEM CELL ADIPOSE VS BONE UP | 126 | 92 | All SZGR 2.0 genes in this pathway |
SWEET LUNG CANCER KRAS UP | 491 | 316 | All SZGR 2.0 genes in this pathway |
BOYAULT LIVER CANCER SUBCLASS G1 DN | 40 | 26 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS DN | 1972 | 1213 | All SZGR 2.0 genes in this pathway |
HECKER IFNB1 TARGETS | 95 | 54 | All SZGR 2.0 genes in this pathway |